US Edition
APEX Biologix Enters Exclusive U.S. Distribution Agreement with Bioventus LLC for XCELL PRP® System – Ortho Spine News
Summary by Ortho Spine News | Your Trusted Voice for Medical Device Industry Ortho News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
APEX Biologix Enters Exclusive U.S. Distribution Agreement with Bioventus LLC for XCELL PRP® System – Ortho Spine News
CLEARWATER, FL, UNITED STATES, May 20, 2025 /EINPresswire.com/ — APEX Biologix, a leading provider of advanced biologic interventions and regenerative medicine solutions, is pleased to announce an exclusive distribution agreement with Bioventus for the XCELL PRP system throughout the United States for orthopedics and sports medicine. This collaboration utilizes one of APEX Biologix’s cutting-edge autologous biologic technologies that allows Biove
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
